Welcome to LookChem.com Sign In|Join Free
  • or
Nalpha-[(benzyloxy)carbonyl]-N-[(3-bromo-4,5-dihydro-1,2-oxazol-5-yl)methyl]-L-tyrosinamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

744198-19-4

Post Buying Request

744198-19-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

744198-19-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 744198-19-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,4,4,1,9 and 8 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 744198-19:
(8*7)+(7*4)+(6*4)+(5*1)+(4*9)+(3*8)+(2*1)+(1*9)=184
184 % 10 = 4
So 744198-19-4 is a valid CAS Registry Number.

744198-19-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name benzyl N-[(2S)-1-[(3-bromo-4,5-dihydro-1,2-oxazol-5-yl)methylamino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]carbamate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:744198-19-4 SDS

744198-19-4Upstream product

744198-19-4Downstream Products

744198-19-4Relevant academic research and scientific papers

Medical Devices and Coatings Therefor

-

, (2009/01/20)

A coating for a medical device, the device generally being of the type which is to be used internally in a subject, includes a transglutaminase (TGase) inhibitor. The Tgase inhibitor effectively prevents the activity of any Tgase involved in clot formation or clot stability. Preferably, the transglutaminase inhibitor is a factor XIIIa inhibitor. The coating may be prepared by suitable processes such as esterification. The coating may be immobilized on a suitable medical device in a number of ways and is preferably included in a TGase inhibitor containing polymer. The coating may also include a suitable antimicrobial agent.

3,5-substituted 4,5-dihydroisoxazoles as transglutaminase inhibitors

-

, (2008/06/13)

The present invention is directed to certain 3,5 substituted, 4,5-dihydroisoxazoles, and methods for their use. These compounds are transgulatminase inhibitors, and are particularly effective in the inhibition of epidermal transglutaminase and the treatment of acne.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 744198-19-4